NCT07281365

Brief Summary

The goal of this study is to develop and test an outpatient intervention for preadolescents (ages 7-12) with self-injurious thoughts and behaviors (SITBs). The main questions it aims to answer are:

  1. 1.Are the recruitment targets and study design feasible?
  2. 2.Is the new intervention feasible, acceptable, and appropriate?
  3. 3.Does the new intervention lead to more improvements in SITBs, mental health symptoms, and treatment targets relative to treatment as usual (TAU)?
  4. 4.Complete an initial baseline assessment to determine eligibility and assess SITBs, mental health symptoms, executive functioning, and emotion regulation
  5. 5.Participate in an intervention lasting 6-12 weeks, including weekly or biweekly sessions
  6. 6.Complete additional assessments at post-treatment and 3-month follow-up
  7. 7.Participate in an interview sharing their perceptions of the intervention

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
17mo left

Started Dec 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 1, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 15, 2025

Completed
12 months until next milestone

Study Start

First participant enrolled

December 1, 2026

Expected
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2028

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2028

Last Updated

July 29, 2026

Status Verified

July 1, 2026

Enrollment Period

1.4 years

First QC Date

December 1, 2025

Last Update Submit

July 27, 2026

Conditions

Keywords

PreadolescentsChildrenSelf-InjurySuicidal ideation and behaviorFeasibilityPilot Trial

Outcome Measures

Primary Outcomes (1)

  • Feasibility of recruitment

    % recruitment targets met (benchmark = 52 preadolescents enrolled within 13 months)

    Calculated at enrollment

Secondary Outcomes (9)

  • Suicidal Ideation Intensity

    From enrollment to 3-month follow-up at 20 weeks

  • Feasibility of Retention

    From enrollment to the end of treatment at 8 weeks

  • Perceived Appropriateness of Intervention

    From enrollment to the end of treatment at 8 weeks

  • Perceived Feasibility of Intervention

    From enrollment to the end of treatment at 8 weeks

  • Perceived acceptability of intervention

    From enrollment to the end of treatment at 8 weeks

  • +4 more secondary outcomes

Other Outcomes (8)

  • Anxiety Symptoms

    From enrollment to 3-month follow-up at 20 weeks

  • Depression Symptoms

    From enrollment to 3-month follow-up at 20 weeks

  • Disruptive Behavior Symptoms

    From enrollment to 3-month follow-up at 20 weeks

  • +5 more other outcomes

Study Arms (2)

Preadolescent SITB Intervention

EXPERIMENTAL

Experimental intervention for preadolescent SITBs targeting executive functioning, emotion regulation, and other SITB risk factors

Behavioral: Preadolescent SITB Intervention

Treatment as Usual (TAU)

ACTIVE COMPARATOR

Treatment as Usual provided by outpatient mental health therapist

Behavioral: Treatment as usual (TAU)

Interventions

Typical interventions Outpatient therapist would provide to a preadolescent with SITBs, based on their clinical judgement

Treatment as Usual (TAU)

Experimental intervention developed with end-users and experts to target emotion regulation, executive functioning, and other risk factors for SITBs in preadolescents

Preadolescent SITB Intervention

Eligibility Criteria

Age7 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • between the ages of 7-12
  • at least one caregiver/legal guardian able to participate (more permitted)
  • experienced at least one episode of SITBs within the last month
  • ability to attend weekly sessions in-person or via telehealth
  • ability to attend baseline and post-treatment assessments in-person.
  • estimated verbal IQ of 70 or greater

You may not qualify if:

  • symptoms interfering with ability to participate in assessments/therapy (i.e., psychosis)
  • estimated verbal IQ\<70 or previous diagnosis of intellectual development disorder
  • requiring inpatient psychiatric stabilization or high-intensity intervention to prevent hospitalization
  • active substance use
  • ward of the state

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital Colorado

Aurora, Colorado, 80045, United States

Location

MeSH Terms

Conditions

Self-Injurious BehaviorSuicidal IdeationBehaviorEmotional Regulation

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Behavioral SymptomsSuicideSelf-ControlSocial Behavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 1, 2025

First Posted

December 15, 2025

Study Start (Estimated)

December 1, 2026

Primary Completion (Estimated)

May 1, 2028

Study Completion (Estimated)

May 1, 2028

Last Updated

July 29, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will share

IPD from the randomized controlled trial will be shared with the NIMH National Data Archive.

Shared Documents
STUDY PROTOCOL, SAP, ICF

Locations